Increasing proportion of herpes simplex virus type 1 among women and men diagnosed with first-episode anogenital herpes: a retrospective observational study over 14 years in Melbourne, Australia.


Journal

Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554

Informations de publication

Date de publication:
06 2019
Historique:
received: 02 09 2018
revised: 15 11 2018
accepted: 25 11 2018
pubmed: 17 12 2018
medline: 5 11 2019
entrez: 17 12 2018
Statut: ppublish

Résumé

Reports of rising herpes simplex virus type 1 (HSV-1) genital infections relative to HSV-2 have been published up to 2006 in Australia. These changes have been attributed to declining childhood immunity to HSV-1. We described the temporal trends of HSV-1 and HSV-2 up to 2017 in Melbourne, Australia, to determine if the earlier trend is continuing. We conducted a retrospective review of the medical records of 4517 patients who were diagnosed with first episode of anogenital HSV infection at the Melbourne Sexual Health Centre, Australia, between January 2004 and December 2017. HSV-1 and HSV-2 were calculated as a proportion of all first episode of anogenital HSV infections. The change in the proportions of HSV-1 and HSV-2 over time was assessed by a χ The proportion of first episode of anogenital herpes due to HSV-1 increased significantly over time in women (from 45% to 61%; p The proportion of first-episode anogenital herpes due to HSV-1 has been rising in women since 2004. HSV-1 has become the leading cause of anogenital herpes in younger populations, women and MSM.

Identifiants

pubmed: 30554143
pii: sextrans-2018-053830
doi: 10.1136/sextrans-2018-053830
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

307-313

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: Melbourne Sexual Health Centre has received funding from SpeeDx to undertake research studies on Mycoplasma genitalium. The authors of this paper declare no additional conflicts of interest.

Auteurs

Duygu Durukan (D)

Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia duygu.durukan@monash.edu.
Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Christopher K Fairley (CK)

Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.
Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Catriona S Bradshaw (CS)

Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.
Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Tim R H Read (TRH)

Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.
Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Julian Druce (J)

Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Melbourne, Victoria, Australia.

Michael Catton (M)

Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Melbourne, Victoria, Australia.

Leon Caly (L)

Victorian Infectious Diseases Reference Laboratory, Doherty Institute, Melbourne, Victoria, Australia.

Eric P F Chow (EPF)

Melbourne Sexual Health Centre, Alfred Health, Carlton, Victoria, Australia.
Central Clinical School, Monash University, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH